Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|May 26, 2012
Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cellsSilvia Monticone, Namita G Hattangady, Koshiro Nishimoto, et al.
Hypertension (Dallas, Tex. : 1979)|September 22, 2010
The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levelsNienke van Leeuwen, Massimiliano Caprio, Carolina Blaya, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2011
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumorsWiebke Arlt, Michael Biehl, Angela E Taylor, et al.
European Journal of Endocrinology|February 11, 2017
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter studyMaria Vittoria Davi', Elisa Cosaro, Serena Piacentini, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2016
Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg MutationCristina L Ronchi, Guido Di Dalmazi, Simon Faillot, et al.
Journal of the American College of Cardiology|December 13, 2006
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patientsGian Paolo Rossi, Giampaolo Bernini, Chiara Caliumi, et al.
Hypertension (Dallas, Tex. : 1979)|May 29, 2014
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenomaFabio Luiz Fernandes-Rosa, Tracy Ann Williams, Anna Riester, et al.
The Journal of Clinical Endocrinology and Metabolism|September 8, 2005
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month studyGianluca Aimaretti, Maria Rosaria Ambrosio, Carolina Di Somma, et al.
The New England Journal of Medicine|June 8, 2007
Adjuvant mitotane treatment for adrenocortical carcinomaMassimo Terzolo, Alberto Angeli, Martin Fassnacht, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
Pageof 15